Zylera’s BONISARA™ (strontium gluconate 680mg and ranamine 30mg) is a proprietary form of strontium, which has been shown in extensive clinical trials to have a unique mechanism of action in that it operates on both pathways—bone loss and bone formation. The strontium in BONISARA works to stimulate the replication of osteoprogenitor cells and collagens as well as non-collagenic protein synthesis in osteoblasts thereby enhancing bone formation. Additionally, the unique chemical makeup of BONISARA also works to foster a decrease in bone loss at the cellular and tissue level.